Cargando…
Characterization and Validation of a Human 3D Cardiac Microtissue for the Assessment of Changes in Cardiac Pathology
Pharmaceutical agents despite their efficacy to treat disease can cause additional unwanted cardiovascular side effects. Cardiotoxicity is characterized by changes in either the function and/or structure of the myocardium. Over recent years, functional cardiotoxicity has received much attention, how...
Autores principales: | Archer, Caroline R., Sargeant, Rebecca, Basak, Jayati, Pilling, James, Barnes, Jennifer R., Pointon, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033897/ https://www.ncbi.nlm.nih.gov/pubmed/29976997 http://dx.doi.org/10.1038/s41598-018-28393-y |
Ejemplares similares
-
Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues
por: Reyat, Jasmeet S., et al.
Publicado: (2023) -
Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues
por: Ravenscroft, Stephanie M., et al.
Publicado: (2016) -
Vascularized hiPSC-derived 3D cardiac microtissue on chip
por: Arslan, Ulgu, et al.
Publicado: (2023) -
Vascularized hiPSC-derived 3D cardiac microtissue on chip
por: Arslan, Ulgu, et al.
Publicado: (2023) -
Isochoric supercooled preservation and revival of human cardiac microtissues
por: Powell-Palm, Matthew J., et al.
Publicado: (2021)